Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.6B | 19.6B | 20.3B | 20.1B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.7B | 7.3B | 7.4B | 7.2B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.4B | 3.8B | 4.4B | 4.3B |
Tax provision | 1.3B | 912M | 1.1B | 1.0B |
Net income | 4.1B | 2.9B | 3.3B | 3.3B |
Basic EPS | 0.3 | 0.2 | 0.3 | 0.3 |
Diluted EPS | 0.3 | 0.2 | 0.3 | 0.3 |
Basic average shares | 11.3B | 11.3B | 11.4B | 11.4B |
Diluted average shares | 11.5B | 11.6B | 11.6B | 11.7B |
EBITDA | — | — | — | — |
Net income from continuing op. | 4.1B | 2.9B | 3.2B | 3.2B |
Minority interests | -43M | -34M | -35M | -46M |
Preferred stock dividends | 44M | 37M | 56M | 32M |